Skip to content

Peritrochanteric Nail System 29202

by Biomet Orthopedics, Inc.

Peritrochanteric Nail System 29202 is a Class II device made by Biomet Orthopedics, Inc., cleared under FDA 510(k) K050118 on 16 Feb 2005 (1 earlier submission) and listed in FDA GUDID since 24 Oct 2015 (UDI-DI 00888480262602), active as of 23 Oct 2026. 17 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

18 closed

Documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00888480262602 UDI-DI Date24 Oct 2015ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK050118 Date16 Feb 2005DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K050118 decided 16 Feb 2005 Active· +1 more in the status table
  • FDA GUDID UDI-DI 00888480262602 listed 24 Oct 2015 Listed

Recalls

18 recalls · FDA

  • 13 recalls, same reason

    • Terminated Z-2235-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2231-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2240-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2242-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2241-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2234-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2233-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2236-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2239-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2237-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2238-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2230-2018 FDA Class II initiated 16 May 2018
    • Terminated Z-2232-2018 FDA Class II initiated 16 May 2018

    The firm is recalling various trauma guide wires due to insufficient packaging design verification and exceeding the expected occurrence rate of complaints for sterile barrier failure. Guide wires packaged in the affected packaging configuration have the potential for sterile barrier breach, leading to possible risk for infection.

    • Terminated Z-0087-2017 FDA Class II initiated 2 Aug 2016

    The G-PIN 2.8BL 3.2PL 60 CM 2PK is intended to contain one (1) 467265-01 Ball Tip Guide Pin and one (1) 467255-02 Plain Tip Guide Pin. The G-PIN 2.8BL 3.2PL 60 CM 2PK may have been packaged incorrectly either with two (2) 467265-01 Ball Tip Guide Pins and zero (0) 467255-02 Plain Tip Guide Pins or with zero (0) 467265-01 Ball Tip Guide Pins and two (2) 467255-02 Plain Tip Guide Pins. If the G-PIN 2.8BL 3.2PL 60 CM 2PK contains the incorrect combination of Plain Tip Guide Pins and Ball Tip Guide Pins, the surgeon would either have to implant the nail without the Plain Tip Guide Pin as a guide, ream with a Plain Tip Guide Pin, or choose to not ream the humeral canal. The risk associated with not having the correct combination can include a delay in surgery of less than 30 minutes, the reamer tip remaining in the distal humeral canal, or an iatrogenic fracture.

  • 2 recalls, same reason

    • Terminated Z-1822-2016 FDA Class II initiated 1 Apr 2016
    • Terminated Z-1819-2016 FDA Class II initiated 1 Apr 2016

    Insufficient seal strength on sterile barrier packaging. The seal could be jeopardized causing the sterile barrier to be compromised and the product could become nonsterile. If the product becomes non-sterile and is used or implanted, it may lead to an infection.

    • Terminated Z-1478-2012 FDA Not yet classified initiated 30 Mar 2012

    The Trochanteric Nail, lot 486130, was mislabeled as a right nail orientation but the contents are actually a left nail orientation

    • Terminated Z-0012-06 FDA Unclassified (pre-2012) initiated 24 Jun 2005 on shared 510(k) K050118

    Upon evaluation, the firm found that the fatigue strength of these nails was below the required value as specified in the design specification.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

21 dated events

  1. Recall initiated FDA recalls Z-2242-2018
  2. Recall initiated FDA recalls Z-2241-2018
  3. Recall initiated FDA recalls Z-2234-2018
  4. Recall initiated FDA recalls Z-2233-2018
  5. Recall initiated FDA recalls Z-2236-2018
  6. Recall initiated FDA recalls Z-2239-2018
  7. Recall initiated FDA recalls Z-2237-2018
  8. Recall initiated FDA recalls Z-2238-2018
  9. Recall initiated FDA recalls Z-2230-2018
  10. Recall initiated FDA recalls Z-2232-2018

11 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Peritrochanteric Nail System
Generic name
Bone nail implantable cap
Model / Ref / Catalog
29202
Primary DI / UDI-DI
00888480262602
510(k) Number
FDA product code
HSB, HTY
GMDN term
Bone nail implantable cap
Device class
Class II
Regulation number
888.3020, 888.3040
GUDID distribution status
In Commercial Distribution

Other devices from Biomet Orthopedics, Inc.

See all devices from Biomet Orthopedics, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)